Physician profile
John A Muenz
NPI 1811030430
$14,198.52
in general payments reported to CMS, 2019-2025
75 companies · $1,753 in 2025
The $1,753 reported for 2025 was more than what 94% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,772 · 2020: $1,880 · 2021: $2,782 · 2022: $2,288 · 2023: $2,144 · 2024: $1,579 · 2025: $1,753.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,476.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,571.18 | 2019-2024 | Enbrel, Otezla, Repatha |
| Abbvie INC. | $1,301.17 | 2021-2025 | |
| Novo Nordisk INC | $879.64 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $742.65 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Allergan, INC. | $696.95 | 2019-2022 | |
| Glaxosmithkline, LLC. | $640.24 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $501.72 | 2021-2025 | Jardiance, Synjardy, Ofev |
| Bayer Healthcare Pharmaceuticals INC. | $393.55 | 2022-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $381.13 | 2019-2024 | Xifaxan |
| Pfizer INC. | $370.07 | 2019-2024 | |
| Lundbeck LLC | $329.88 | 2020-2024 | Rexulti |
| Pear Therapeutics (US), INC. | $306.94 | 2021 | |
| Orexo US, INC. | $287.24 | 2019-2021 | |
| Gilead Sciences, INC. | $281.26 | 2019-2021 | |
| Astrazeneca Pharmaceuticals LP | $280.33 | 2022-2025 | Farxiga, Airsupra, Breztri |
Show all 75 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $278.18 | 2022 | |
| Medtronic, INC. | $269.88 | 2023-2024 | Synchromedii |
| Novartis Pharmaceuticals Corporation | $254.05 | 2019-2024 | |
| Indivior INC. | $252.97 | 2019-2025 | Sublocade |
| Boston Scientific Corporation | $247.02 | 2019-2021 | |
| Abbott Laboratories | $245.00 | 2020-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Cequr Corporation | $200.02 | 2025 | Cequr Simplicity |
| Otsuka America Pharmaceutical, INC. | $199.77 | 2021-2024 | Rexulti |
| Ethicon INC. | $188.86 | 2025 | Monarch Platform |
| Abiomed | $181.44 | 2023-2025 | Impella |
| Collegium Pharmaceutical, INC. | $165.47 | 2019-2021 | |
| Edwards Lifesciences Corporation | $164.65 | 2025 | Sapien 3 Ultra Resilia |
| Teva Pharmaceuticals USA, INC. | $157.30 | 2020-2021 | |
| Medtronic USA, INC. | $140.78 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $137.24 | 2020-2021 | |
| Vertos Medical, INC. | $123.34 | 2021 | |
| Exact Sciences Corporation | $113.07 | 2023-2025 | Cologuard Collection Kit |
| Upsher-Smith Laboratories LLC | $106.39 | 2020-2021 | |
| Redhill Biopharma INC. | $99.51 | 2020-2021 | |
| Daiichi Sankyo INC. | $87.66 | 2022-2023 | Injectafer |
| Braeburn INC. | $79.43 | 2024 | Brixadi |
| Mdd US Operations, LLC | $78.08 | 2020 | |
| Hologic Sales and Service, LLC | $74.12 | 2022-2025 | Aptima |
| Painteq LLC | $74.08 | 2023 | Painteq |
| Horizon Therapeutics Plc | $73.67 | 2021-2023 | Krystexxa |
| Janssen Pharmaceuticals, INC | $73.50 | 2021-2023 | Xarelto, Spravato |
| Biohaven Pharmaceuticals, INC. | $71.03 | 2021 | |
| Axsome Therapeutics, INC. | $70.29 | 2024-2025 | Auvelity, Sunosi |
| Alkermes, INC. | $63.57 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $63.34 | 2019 | |
| Flowonix Medical Incorporated | $62.81 | 2019 | |
| Merck Sharp & Dohme LLC | $59.45 | 2023 | Dificid |
| Xeris Pharmaceuticals, INC. | $55.77 | 2022-2024 | Gvoke Hypopen, Keveyis |
| Phathom Pharmaceuticals, INC. | $50.95 | 2024-2025 | Voquezna |
| Ucb, INC. | $50.67 | 2022 | |
| Tersera Therapeutics LLC | $44.24 | 2019 | |
| Corcept Therapeutics | $41.96 | 2025 | Korlym |
| Philips North America LLC | $39.60 | 2025 | Extended Holter |
| Astellas Pharma US INC | $37.14 | 2024 | Veozah |
| Ferring Pharmaceuticals INC. | $33.03 | 2021-2022 | |
| Kaleo, INC. | $32.26 | 2019 | |
| Hikma Pharmaceuticals USA | $30.57 | 2023-2024 | Ryaltris, Kloxxado, Mitigare |
| Vanda Pharmaceuticals INC. | $29.15 | 2025 | Fanapt |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $28.61 | 2024-2025 | Caplyta |
| Eisai INC. | $28.38 | 2020-2022 | |
| Verrica Pharmaceuticals INC. | $24.58 | 2025 | Ycanth |
| Optinose US, INC. | $24.36 | 2025 | |
| Paratek Pharmaceuticals, INC. | $23.42 | 2025 | Xhance, Nuzyra |
| Uswm, LLC | $23.03 | 2021 | |
| Nevro Corp. | $21.36 | 2019 | |
| Zimmer Biomet Holdings, INC. | $20.83 | 2019 | |
| Scilex Pharmaceuticals INC. | $20.63 | 2022 | |
| Dexcom, INC. | $17.73 | 2023 | Dexcom G6 Transmitter |
| Clarus Therapeutics INC. | $17.42 | 2021 | |
| Jazz Pharmaceuticals INC. | $15.14 | 2021 | |
| Kerecis Limited | $14.54 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Bausch Health US, LLC | $13.72 | 2024 | Wellbutrin, Aplenzin |
| Irhythm Technologies, INC. | $13.66 | 2024 | Zio Monitor, Zio Xt Patch |
| Sanofi-Aventis U.S. LLC | $13.00 | 2022 | |
| Idorsia Pharmaceuticals US INC | $12.85 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Muenz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.